General AML

Gert Ossenkoppele | EHA 2018 | Non-intensive treatment strategies in AML: New hope for unfit AML patients

L:

At the 2018 European Hematology Assiociation Meeting, Gert Ossenkoppele (chair our Global and European steering committee) from VU Medical Center, Amsterdam, NL, talks about non-intensive treatment strategies for elderly acute myeloid leukemia (AML) including the use of venetoclax in combination with hypomethylating agents.

Download this article:

You can now download this article in Adobe PDF® format.

Download as PDF